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To determine the diagnostic accuracy of physicians’ prior probability estimates of serious infection in critically
ill neonates and children, we conducted a prospective cohort study in 2 intensive care units. Using available
clinical, laboratory, and radiographic information, 27 physicians provided 2567 probability estimates for 347
patients (follow-up rate, 92%). The median probability estimate of infection increased from 0% (i.e., no
antibiotic treatment or diagnostic work-up for sepsis), to 2% on the day preceding initiation of antibiotic
therapy, to 20% at initiation of antibiotic treatment ( ). At initiation of treatment, predictions discrim-P ! .001
inated well between episodes subsequently classified as proven infection and episodes ultimately judged unlikely
to be infection (area under the curve, 0.88). Physicians also showed a good ability to predict blood culture-
positive sepsis (area under the curve, 0.77). Treatment and testing thresholds were derived from the provided
predictions and treatment rates. Physicians’ prognoses regarding the presence of serious infection were re-
markably precise. Studies investigating the value of new tests for diagnosis of sepsis should establish that they
add incremental value to physicians’ judgment.
Decision-making in the presence of uncertainty is a core
task of clinical medicine. A particularly difficult situ-
ation is the management of critically ill neonates and
children who develop symptoms suggestive of serious
infection. Because of the high risk associated with un-
treated bacterial infection, most clinicians favor early
prescription of antibiotic treatment [1, 2]. Despite the
resulting low threshold to initiate antibiotic treatment,
some infants have conditions that escape early diag-
nosis. To improve the accuracy of diagnostic work-up,
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several new diagnostic tests have been suggested [3–8].
However, no single parameter has gained undisputed
acceptance [9–12].
A potential reason for this failure to change clinical
practice is the inherent incompatibility between real-
life conditions and the artificial case-control design of
most studies of diagnostic-test accuracy, in which the
discriminative power of a new diagnostic test is derived
from a subgroup of patients who satisfy unanimously
accepted criteria for being clearly infected (cases) or
not (controls) [13, 14]. This case-control design suffers
from the potential overestimation of the performance
of the diagnostic test being studied [15], since it omits
ambiguous episodes of suspected infection and, more
importantly, disregards any patient information that is
present in addition to the diagnostic test under scrutiny.
This stands in contrast to clinical practice, in which
physicians derive clues about the presence or absence
of infection from the patient’s history, the clinical
course, and laboratory findings. Moreover, the clinical
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evaluation is constantly updated as new diagnostic information
arises. Most of the previously published studies of diagnostic-
test accuracy neither addressed this clinical evolution nor used
a framework which allows integration of the available clinical
judgement with the diagnostic test under scrutiny [14].
Hitherto, clinicians’ prior probability estimates of the pres-
ence or absence of serious infection in critically ill infants and
children have not been evaluated in a systematic fashion. We
therefore conducted a prospective cohort study to obtain daily
predictions and to evaluate the accuracy of physicians’ estimates
on the probability of serious infection, using the commonly
applied case-control design of traditional studies of diagnostic-
test accuracy. The secondary objective was to relate the obtained
probability estimates to the observed clinical management de-
cisions, in order to determine antibiotic-treatment and testing
thresholds.
METHODS
Study design and population. In this prospective, observa-
tional cohort study, physicians estimated the prior probability
of infection daily for every hospitalized patient. During a 3-
month period, we enrolled all consecutive patients admitted to
a tertiary neonatal intensive care unit with 28 level-III beds in
Boston, Massachusetts, and to a tertiary pediatric intensive care
unit with 19 level-III beds in Zurich, Switzerland. The 2 units
provide the entire spectrum of neonatal and pediatric critical
care, except for extracorporal membrane oxygenation.
Data collection. Three trained research fellows obtained
estimates of the presence of bacterial infection from the cli-
nicians responsible for the care of the patients daily (including
weekends) after morning rounds (which included presentation
of history, physical examination, and review of laboratory and
radiographic data) and whenever antibiotic therapy was initi-
ated for suspected infection. At the morning round after ini-
tiation of antibiotic therapy, physicians were asked to update
their probability estimate, taking into account the new labo-
ratory and clinical evidence obtained since initiation of therapy,
but provided that blood culture results were still pending. For
gauging these predictions against an external validity criterion,
physicians also predicted the probability of bacterial growth in
cultures of blood samples obtained during diagnostic work-up
for sepsis. Of the participating physicians (12 attending critical-
care physicians and 15 fellows), fellows with !1 year of intensive
care experience (8 of 15 fellows) were required to consult their
attending physician before providing a prediction. Only 1 daily
prediction per patient was included in the analysis.
Because the best method to obtain probability estimates for
rare events remains controversial [16], we pretested our case
record form and offered 3 different types of scaling categories:
estimation of the probability of infection expressed as odds, as
percentage probability, or according to a visual analog scale
[17]. The final, prevalidated scaling instrument asked for an
exact probability expressed as a percentage, and it provided a
number-entry field plus a row of check-boxes (with the values
0, 1, 2, 3, 5, 10, 15, 20, 25, 30, 40, 50, 75, and 100). The
prediction instrument yielded a repeat-test reliability of 0.79
and an interrater reliability (i.e., rating of the same patient by
2 different physicians) of 0.73. Additional information collected
for each patient included age, sex, weight, reason for hospital
admission, antibiotic exposure, results of microbiologic cul-
tures, and mode of ventilation. (The final version of the data
collection form is available on request from J.E.F.)
Outcome assessment. After discontinuation of a patient’s
antibiotic therapy, 1 of the senior physicians who had not pro-
vided the prediction at initiation of antibiotic therapy and 1
of the investigators independently classified the outcomes re-
lated to each course of antibiotic treatment. Courses of anti-
biotic prophylaxis were excluded from this analysis. Adjudi-
cators were blinded to the physicians’ a priori predictions.
Disagreement was resolved by consensus. Further details on the
adjudication criteria have been reported elsewhere [1]. The
outcome categories were as follows: “proven systemic bacterial
infection,” “proven localized infection,” “probable infection,”
“viral infection” and “infection unlikely or absent.” “Rule-out
treatment” was defined as an episode of unlikely infection in
which antibiotic therapy was discontinued within 48 h after
being initiated and not restarted within 72 h.
Data analysis. Using the Kruskal-Wallis test, physicians’
predictions were compared across different time-points during
the patients’ clinical course. General linear models were em-
ployed to explain the variance of these predictions. The loga-
rithm of the prediction value served as the dependent variable,
with clinical situation, age, sex, predicting physician, and study
site as covariates. We considered the possibility that differences
between the participating intensive care units and between phy-
sicians might affect predictions across clinical situations. There-
fore, we tested 2 possible interaction terms: (1) interaction
between the clinical situation and the participating study unit
and (2) interaction between the clinical situation and the pre-
dicting physician. The final analysis presents the more parsi-
monious interaction term, which was interaction term (1), clin-
ical situation and study unit.
We assessed the discriminative ability of physicians’ predic-
tions at the time of initiation of antibiotic therapy by means
of logistic regression analysis [18], comparing predictions for
patients later determined to have proven systemic bacterial in-
fection with predictions obtained from patients with episodes
classified as rule-out treatment. This approach provides com-
parability to similar studies of diagnostic-test accuracy in the
field and is least prone to classification bias [3–7]. The analysis
was repeated for predictions obtained during the day preceding
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Table 1. Demographic and clinical characteristics of a cohort of pediatric
patients in a study of the diagnostic accuracy of physicians’ prognostications
regarding serious bacterial infection.
Characteristic
Patients
(n p 347)
Hospital days
(n p 2785)
Male sex 195 (56.2) 1768 (63.5)
Patient age
Premature infants
Aged !28 weeks 38 (11.0) 733 (26.3)
Aged 28–31.9 weeks 31 (8.9) 246 (8.8)
Aged 32–36.9 weeks 43 (12.4) 188 (6.8)
Term newborns 93 (26.8) 394 (14.1)
Infants aged 1–12 months 53 (15.3) 746 (26.8)
Children aged 1–5 years 40 (11.5) 303 (10.9)
Children aged 15 years 49 (14.1) 175 (6.3)
Median age in months (interquartile range) 0.2 (0–13) 0.5 (0–5.4)
Main reasons for admission
Prematurity 87 (25.1) 1018 (36.6)
Respiratory distress or respiratory disease 55 (15.8) 321 (11.5)
Other neonatal disorder 10 (2.9) 18 (0.6)
Congenital malformation, noncardiac 14 (4.0) 75 (2.7)
Congenital heart disease requiring surgery 32 (9.2) 428 (15.4)
Congenital heart disease without surgery 15 (4.3) 98 (3.5)
Surgery, noncardiac 33 (9.5) 158 (5.7)
Infectious condition 47 (13.6) 249 (8.9)
Neurological disorder 21 (6.1) 173 (6.2)
Impending circulatory failure 12 (3.5) 53 (1.9)
Trauma 10 (2.9) 34 (1.2)
Metabolic disorder 7 (2.0) 11 (0.4)
Othera 4 (1.1) 149 (5.4)
Ventilation
Intratracheal mechanical 230 (66.3) 1604 (57.6)
Noninvasive 63 (18.2) 225 (8.1)
Antibiotic exposure
Treatment for suspected infectionb 188 (54.2) 1046 (37.6)
Perioperative and other prophylaxisc 47 (13.6) 170 (6.1)
NOTE. Data are no. (%) of patients or hospital days, unless indicated otherwise.
a One hundred forty-six hospital days were contributed by 1 male infant with Undine
syndrome.
b Some patients received 11 course of treatment for suspected infection.
c “Other” includes 7 patients who received systemic prophylaxis because of severe
immunosuppression.
initiation of antibiotic therapy and for the updated predictions
obtained during the morning round after initiation of antibiotic
therapy. Sensitivity analyses used a broadened case definition,
which included episodes of proven localized infection or prob-
able infection. Using this broadened case definition, we checked
the stability of the estimates after adjusting for potential con-
founding by participating unit, patient sex, and patient ges-
tational age (modeled as a categorical variable). The Hosmer
and Lemeshow goodness-of-fit statistics were employed to test
the calibration of the models [19]. This method assesses
whether a prediction model is well-calibrated across a possible
range of predictions. A poor fit is indicated by a “significant”
P value; a large P value indicates good calibration.
We derived thresholds from observed prescription and test-
ing patterns by analyzing predictions provided before and at
the time of initiation of antibiotic treatment. The proportion
of patients receiving antibiotics was plotted against strata of
predictions (percentage probabilities of 0, 1–3, 5–10, 10–20,
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Table 2. Daily predictions for different clinical situations in a cohort of pediatric patients in a study of the
diagnostic accuracy of physicians’ prognostications regarding serious bacterial infection.
Clinical situation
No. of
predictions
made
Predicted probability of infection, %
PaMedian (IQR)
10th–90th
percentile Mean  SEM
No antibiotic therapy, no symptoms 1299 0 (0–2) 0–5 2.3  0.2 Reference
No antibiotic therapy, no diagnostic testing 733 0 (0–1) 0–2 1.2  0.2 !.01
24 h prior to initiation of antibiotic therapy 70 2 (0–10) 0–50 11.4  2.6 !.01
At initiation of antibiotic therapy 162 20 (5–75) 2–100 38.0  2.9 !.01
Stratified by time of initiation
Initiation at admission 90 10 (3–75) 2–100 33.3  4.1 Reference
Initiation during hospitalization 72 45 (5–75) 2–100 43.0  5.2 !.01
Stratified by age at initiation
Premature infants, aged !32 weeks 54 7 (4–30) 2–60 21.3  3.4 Reference
Neonates, aged 32–44 weeks 34 4 (2–8) 0–10 8.0  2.4 !.05
Infants, aged 1–12 months 52 75 (38–100) 5–100 62.7  4.9 !.01
Children, aged 11 year 22 75 (25–100) 5–100 66.8  8.0 !.01
Day after initiation of antibiotic therapy 181 10 (2–60) 0–100 31.0  2.9 !.01
At discontinuation of antibiotic therapy 138 1 (0–2) 0–5 2.1  0.3 1.2
NOTE. IQR, interquartile range.
a Group-wise comparisons with the reference category, using nonparametric tests.
20–40, 40–70, 70–100), and a regression curve was fit through
these data points. We defined the treatment threshold as the
predicted probability of infection that corresponded to a treat-
ment rate of 50%. We derived the testing threshold from the
results of all predictions obtained when patients did not receive
antibiotics and did not have laboratory tests performed. The
testing threshold was defined as the 75th percentile of these
prediction values [14].
Standard definitions of sensitivity, specificity, and likelihood
ratio were used [14, 18]. We constructed receiver operating
characteristic (ROC) curves, which graphically represent the
true-positive rate (sensitivity) and the false-positive rate (1-
specificity) for a range of cutoff points [20]. The areas under
the receiver operating characteristic curve (ROCa) were deter-
mined using the algorithm suggested by Hanley and McNeil
[21]. The greater the ROCa value, the more discriminative the
diagnostic test or prediction: an ROCa value of 1.0 indicates a
perfectly discriminative result, whereas an ROCa value of 0.5
indicates a nondiscriminative result.
All analyses were performed using SAS software, version 6.12
(SAS Institute). Tests were 2-tailed, with indicating sta-P ! .05
tistical significance.
RESULTS
Three hundred forty-seven patients contributed 2785 hospital
days to the study. Important demographic and clinical char-
acteristics of the patient cohort are shown in table 1. Predictions
were obtained for 2567 hospital days (follow-up rate, 92%).
Data were missing and were omitted from the analysis for 218
hospital days because of early patient discharge ( ), pe-np 126
riods of extreme workload ( ), or ambiguous marks onnp 78
the data collection form ( ).np 14
Outcomes. A total of 188 patients received 219 courses of
antibiotic treatment for episodes of suspected infection, of
which 183 courses were initiated after hospital admission. An
additional 57 courses of antibiotics were prescribed as pro-
phylaxis for 47 patients. Overall, patients were exposed to sys-
temic antimicrobial agents during 1216 hospital days (44% of
all hospital days). Of the 219 courses of antibiotic treatment,
30 (14%) were administered for episodes of ultimately proven
systemic bacterial infection, 36 (16%) for episodes of proven
localized infection, 29 (13%) for episodes of probable infection,
7 (3%) for episodes of viral infection and 117 (53%) for epi-
sodes of unlikely infection, of which 83 (71%) were for rule-
out treatment episodes (38% of all courses).
Predictions. The predicted probability of infection in-
creased as patients progressed from not being treated towards
initiation of antibiotic therapy (table 2). The median probability
estimate of infection increased from 0% (i.e., no antibiotic
treatment or diagnostic work-up for sepsis), to 2% on the day
preceding initiation of antibiotic therapy, to 20% at initiation
of treatment ( ). Figure 1 presents predictions at differ-P ! .001
ent time-points (figure 1A) and stratified by outcome category
(figure 1B). General linear models revealed that the total ex-
plained variance of the predicted probability of infection had
a coefficient (R2) of 0.22 ( ). The clinical situation (be-P ! .001
fore, at, or after initiation of antibiotic therapy) was the single
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Figure 1. Physicians’ predictions of the probability of serious bacterial infection in pediatric patients. Horizontal black bars, median values; vertical
boxes, interquartile range; vertical lines, 10th–90th percentiles. A, Predictions at different time-points during the patients’ clinical course. B, Predictions,
stratified by outcome categories (see Methods for details). Box plots with horizontal shading show probability estimates at initiation of antibiotic
therapy (AB); box plots without shading display the prognostications on the day after initiation of antibiotic therapy.
most important factor for estimating the probability of infec-
tion; it explained 15% of the observed variance. Other factors
(i.e., study unit, age, and predicting physician) explained 7%
of the variance. Addition of a term for interaction between the
clinical situation and the study unit did not result in a signif-
icant effect.
Diagnostic accuracy. One day prior to initiation of an-
tibiotic therapy, physicians were unable to discriminate between
patients later determined to be clearly infected and those later
classified as uninfected (ROCa, 0.49). However, physicians’ pre-
dictions on the day of initiation of antibiotic therapy discrim-
inated well between episodes subsequently classified as proven
systemic bacterial infection and those ultimately classified as
rule-out treatment episodes (ROCa, 0.88; 95% CI, 0.81–0.94;
figure 2). With a cut-off point of the predicted probability of
25%, the sensitivity was 0.87 (95% CI, 0.65–0.97) with a cor-
responding likelihood ratio of 5.1 (95% CI, 3.5–7.9). A pre-
diction of !25% yielded a specificity of 0.83 (95% CI, 0.73–
0.90) and a likelihood ratio of 0.16 (95% CI, 0.1–0.2).
Hosmer-Lemeshow x2 statistics revealed a good fit ( ).Pp .63
Results of sensitivity analysis with the broadened case definition
(i.e., proven infection or probable infection) supported the
stability of this estimate (figure 2). Adjusted analysis that con-
trolled for potential confounding effects of age, sex, and study
unit did not alter the estimate (ROCa, 0.89; 95% CI, 0.82–0.94;
, by Hosmer-Lemeshow x2 test). The discriminativePp .91
ability of physicians’ predictions made following the next morn-
ing round after initiation of antibiotic therapy increased to an
ROCa of 0.91 (95% CI, 0.84–0.96).
External validity criterion. Of 225 cultures of blood sam-
ples obtained during diagnostic work-up for sepsis, 23 grew
bacteria, including 9 cultures of blood samples from 2 different
puncture sites (a central line and a peripheral site) that yielded
coagulase-negative staphylococci. Predictions were available for
205 (91%) of these cultures (blood culture positivity rate,
10.7%, 95% CI, 6.8–15.8%). The median predicted probability
of a positive blood culture result was 15% (interquartile range,
10%–100%). Physicians showed a good ability to predict blood
culture-positive sepsis, after adjusting for age and study unit
(ROCa, 0.77; 95% CI, 0.70–0.83; , Hosmer-LemeshowPp .28
x2 test).
Thresholds. Treatment and testing thresholds were derived
from the observed antibiotic treatment rates in relation to dif-
ferent prediction strata. As shown in figure 3, treatment thresh-
olds varied between patient subgroups, with lower thresholds
for the more vulnerable patients. The median treatment thresh-
old corresponded to a predicted probability of infection of 20%
in newborns and of 50% in infants aged 11 month. The testing
threshold was 1% in newborns and 2% in infants and children.
DISCUSSION
In this prospective study, physicians’ a priori predictions at the
time of initiation of antibiotic treatment discriminated well
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Figure 2. Receiver operating characteristic curves for the diagnostic
accuracy of physicians’ prognostications regarding serious bacterial in-
fection in pediatric patients. The curve containing squares denotes the
discrimination of cases with culture-proven systemic infection from control
patients in whom infection was ultimately regarded as absent or unlikely.
Triangles indicate the curve employing a broadened case definition com-
prising episodes ultimately classified as proven systemic bacterial infec-
tion, probable systemic infection, or proven localized infection.
between infected and noninfected patients. The diagnostic ac-
curacy of physicians’ judgment was within the range of pub-
lished data for candidate biological markers of sepsis [3–7].
The estimate was stable in various sensitivity analyses. More-
over, physicians showed a good ability to predict positive results
of blood cultures. A recent report on prediction of mortality
in critically ill children showed similar agreement between the
predictions made by experienced clinicians (ROCa, 0.95) and
the prognostication by the best available scoring system based
on physiological data (ROCa, 0.92) [22].
The key issue in the evaluation of candidate tests to use in
the diagnostic work-up for infants or children suspected of
having serious infection is not the diagnostic accuracy alone,
but the diagnostic tests’ clinical usefulness and added value.
Approaches that combine clinical judgment based on all avail-
able information with the additional value of new diagnostic
tests have been proposed, which use either Bayesian methods
or logistic regression analysis [14, 18, 23]. The result of both
approaches is an updated “posttest probability.” If the posttest
probability of serious infection exceeds a certain threshold, cli-
nicians will initiate antibiotic treatment. A very low posttest
probability may rule out infection sufficiently that physicians
withhold antibiotics and refrain from further diagnostic testing
[14]. Within this framework, a clinically useful test would move
pretest probability estimates that are within the boundaries of
uncertainty to posttest probability estimates that are outside
those boundaries [14].
Current data on the clinical usefulness of new diagnostic
markers of sepsis are limited. This is particularly important
regarding the frequent situation when physicians suspect in-
fection and, given current diagnostic strategies, initiate anti-
biotics. In the present study, for the majority of patients who
were later determined to have proven infection, the predictions
exceeded the observed treatment thresholds. This implies that
positive results of laboratory tests would not have added in-
formation contributing to changed antibiotic-treatment deci-
sions. However, negative results of powerful diagnostic tests
could reassure physicians about deciding to withhold or to
consider early discontinuation of antibiotic therapy [24]. Such
tests require excellent sensitivity, to prevent errors in treatment
of infected patients [25]. When combined with physicians’
probability estimates, a test with a negative likelihood ratio of
!0.1 would allow physicians to stop or withhold antibiotic
treatment for 75% of all patients later determined to be un-
infected. However, a test that would support withholding of
antibiotic treatment when infection is already clinically sus-
pected would have to satisfy performance characteristics ex-
ceeding those of any currently available biological marker of
sepsis [14].
The traditional approach for evaluation of a new diagnostic
test cannot assess its clinical usefulness, since it relies on the
retrospective analysis of a subgroup of patients who satisfy
unanimously accepted criteria for being clearly infected (cases)
or not (controls) [13]. This study design inflates the estimates
of a test’s accuracy, since it does not evaluate the more difficult
contrast among a group of similar patients with suspected in-
fection [15]. For this reason, we suggest that future studies
supplement the traditional approach by obtaining daily pre-
dictions on the probability of infection in a group of consec-
utive patients with clinically suspected infection. Combining
physicians’ probability estimates and test results will allow de-
termination of posttest probabilities for every episode of sus-
pected infection, including those with ambiguous classification.
A question of major importance remains: whether clinical
vigilance and constant surveillance has the ability to advance
the early diagnosis of infection in critically ill neonates and
children [5], thus reducing the risk that asymptomatic infection
will progress to septic shock. In our study, 1 day prior to in-
itiation of antibiotic therapy, the predicted probability of in-
fection for patients who subsequently had antibiotic therapy
initiated was significantly higher than for patients who re-
mained untreated. This indicates that physicians were probably
aware of nonspecific clinical signs. However, at that time point,
physicians’ judgement alone was unable to identify patients who
were subsequently classified as clearly infected.
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Figure 3. Treatment threshold curves and regression coefficients for diagnostic accuracy of physicians’ predictions regarding the probability of
serious bacterial infection in pediatric patients before and at initiation of antibiotic treatment. The horizontal axis denotes the predicted probability
of infection, and the vertical axis indicates the related frequency of antibiotic treatment. The size of the circles corresponds to the number of predictions
available from each stratum of predictions for calculation of the regression lines. Bold regression line, treatment rate–prediction curve for all patients;
left dotted line, regression curve for premature infants; right dotted gray line, regression curve fitted through predictions obtained for infants and
children aged 11 month; thin vertical arrows, 50 percent treatment rate, with the corresponding predicted probabilities.
The strengths of this study are that we developed treatment
and testing thresholds from observed clinical data and that
patient outcome was determined by investigators blinded to
the probability estimates. However, some caveats of our study
require consideration. First, treatment thresholds are a matter
of subjective judgement and differ depending on the condition,
the risk of therapy, the availability of tests, and the danger of
the disease if left untreated. Therefore, the thresholds generated
in this study may not be generalizable to adult patients. How-
ever, even if the results are not generalizable, the approach
should be equally valid. Second, we cannot exclude a Haw-
thorne effect (i.e., observational bias) that possibly enhanced
physicians’ discriminative skills [26]. If such an effect was pre-
sent, it did not translate into altered rates of prescription of
antibiotics, as shown by a concurrently conducted observational
study [1]. Finally, the limited number of patients with infection
prevented us from controlling for the observed variance in
predictions between physicians. However, the most likely con-
sequence would be an underestimation of the accuracy of the
predictions. Thus, we believe that our estimate of accuracy is
conservative.
In summary, daily recording of clinicians’ pretest probability
estimates of infection is feasible and provides useful informa-
tion for diagnostic-test accuracy studies. In the present study,
physicians’ prognostications regarding the presence of infection
were remarkably precise. Studies investigating the value of new
tests for diagnosing sepsis should establish that they add in-
cremental value to physicians’ judgment based on currently
available clinical and laboratory parameters.
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